• Policy
• Baricitinib, Heparin, & NOAC were added as COVID-19 benefits
• by Lee, Jeong-Hwan Apr 1, 2021 06:05am

• Policy
• NECA-KSID publish COVID-19 clinical treatment guideline
• by Lee, Hye-Kyung Apr 1, 2021 06:05am

• Policy
• Tamsulosin-mirabegron drug opens competition in Korea
• by Lee, Tak-Sun Apr 1, 2021 06:05am

• Policy
• Generic for Arcoxia were first approved
• by Lee, Tak-Sun Apr 1, 2021 06:05am

• Opinion
• [Reporter’s Eye] How was working from home for a year?
• by Kim, Jin-Gu Mar 31, 2021 06:09am

• Company
• Equfina can be prescribed at general hospitals
• by Eo, Yun-Ho Mar 31, 2021 06:08am

• Company
• “EMA authorizes Rekirona, sales projected at KRW 1.2 tln”
• by Kim, Jin-Gu Mar 31, 2021 06:06am

• Policy
• The NIID-Moderna discusses the cooperation plan for R&D
• by Kim, Jung-Ju Mar 31, 2021 06:06am

• Policy
• Is Forxiga generic same as solvate-modified drug?
• by Lee, Tak-Sun Mar 30, 2021 06:06am

• Policy
• Doctor's note not needed for requesting vaccination leave
• by Kim, Jung-Ju Mar 30, 2021 06:06am